Winton Group LTD Ionis Pharmaceuticals Inc Transaction History

Winton Group LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$31.71 - $43.0 $1.35 Million - $1.83 Million	42,634 New	42,634 $1.58 Million
Q1 2021 Jul 21, 2021	SELL	$42.51 - $63.78 $329,197 - $493,912	-7,744 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$45.3 - $60.27 $4.89 Million - $6.51 Million	-108,007 Reduced 93.31%	7,744 $438,000
Q3 2020 Oct 30, 2020	SELL	$47.45 - $62.95 $418,414 - $555,093	-8,818 Reduced 7.08%	115,751 $5.49 Million
Q2 2020 Aug 05, 2020	BUY	$46.85 - $61.05 $1.98 Million - $2.58 Million	42,209 Added 51.25%	124,569 $7.35 Million
Q1 2020 May 11, 2020	SELL	$41.6 - $63.4 $1.64 Million - $2.5 Million	-39,504 Reduced 32.42%	82,360 $3.89 Million
Q4 2019 Feb 13, 2020	BUY	$53.85 - $65.27 $5.08 Million - $6.16 Million	94,340 Added 342.76%	121,864 $7.36 Million
Q3 2019 Nov 08, 2019	BUY	$59.06 - $72.15 $1.2 Million - $1.46 Million	20,286 Added 280.27%	27,524 $1.65 Million
Q2 2019 Jul 08, 2019	BUY	$62.09 - $86.14 $449,407 - $623,481	7,238 New	7,238 $465,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.83B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.